Dr. Odette Louise Campbell , MD
Internal Medicine • Plano, TX
5072 W Plano Pkwy Ste 220
Plano, TX 750934475
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Odette Campbell is listed in NPPES under Internal Medicine.
-
NPI assigned on April 5, 2006; this date does not establish years in practice.
-
Published CMS data list 31,290 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 87798 — Detection test by nucleic acid for organism, amplified probe technique: 7,138 service units.
- G0483 — Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms: 4,495 service units.
- 80307 — Testing for presence of drug, by chemistry analyzers: 3,212 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 58 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 46,945 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) — 2,142 prescription fills, including refills.
- Amlodipine Besylate — 1,765 prescription fills, including refills.
- Albuterol Sulfate Hfa (Albuterol Sulfate) — 1,678 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 334 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Plano, TX (2024, 156 clinicians with data). Median for this group: 992. Middle half: 489 to 2,558.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,420 clinicians with data). Median for this group: 644. Middle half: 277 to 1,324.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 21,035 in 2020 to 31,290 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
5072 W Plano Pkwy Ste 220
Plano, TX 750934475
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
984 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $2,712,520 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $2,507,644 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
86,063 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$6,696,396 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $25.42 in 2025
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2025.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Compared with the same specialty in Plano and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Plano, TX (2024, 156 clinicians with data). Median for this group: 992. Middle half: 489 to 2,558.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,420 clinicians with data). Median for this group: 644. Middle half: 277 to 1,324.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Plano, TX (2024, 156 clinicians with data). Median for this group: $90,300. Middle half: $44,653 to $172,877.
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,420 clinicians with data). Median for this group: $61,173. Middle half: $27,477 to $116,014.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in Plano, TX (2024, 156 clinicians with data). Median for this group: $70,886. Middle half: $32,670 to $136,657.
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,420 clinicians with data). Median for this group: $47,441. Middle half: $20,511 to $90,151.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Internal Medicine in Plano, TX (2024, 153 clinicians with data). Median for this group: 1,280. Middle half: 151 to 4,707.
More Part D prescriptions than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,692 clinicians with data). Median for this group: 815. Middle half: 119 to 4,814.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Plano, TX (2024, 153 clinicians with data). Median for this group: $86,937. Middle half: $9,405 to $322,827.
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,692 clinicians with data). Median for this group: $62,823. Middle half: $3,924 to $436,115.
213 active clinicians are listed under Internal Medicine with a practice address in Plano, TX (9,244 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Plano
31.5% of these 213 clinicians have the CMS telehealth indicator.
72.3% of these 213 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 49% from 21,035 in 2020 to 31,290 in 2024.
- 2020: 21,035
- 2021: 37,548
- 2022: 31,951
- 2023: 19,762
- 2024: 31,290
-
Medicare-allowed amount
Medicare-allowed amount increased 41% from $1,922,648 in 2020 to $2,712,520 in 2024.
- 2020: $1,922,648
- 2021: $3,123,246
- 2022: $2,800,854
- 2023: $2,199,618
- 2024: $2,712,520
-
Paid by Medicare
Paid by Medicare increased 54% from $1,632,791 in 2020 to $2,507,644 in 2024.
- 2020: $1,632,791
- 2021: $2,848,925
- 2022: $2,537,341
- 2023: $1,988,510
- 2024: $2,507,644
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 22% from 38,525 in 2020 to 46,945 in 2024.
- 2020: 38,525
- 2021: 34,286
- 2022: 38,017
- 2023: 38,241
- 2024: 46,945
-
30-day fills
30-day fills increased 35% from 63,764 in 2020 to 86,063 in 2024.
- 2020: 63,764
- 2021: 58,592
- 2022: 66,941
- 2023: 66,675
- 2024: 86,063
-
Part D drug cost
Part D drug cost increased 67% from $3,999,983 in 2020 to $6,696,396 in 2024.
- 2020: $3,999,983
- 2021: $4,412,573
- 2022: $5,549,840
- 2023: $6,643,323
- 2024: $6,696,396
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $107.53 in 2019 to $25.42 in 2025.
- 2019: $107.53
- 2022: $12.57
- 2023: $46.89
- 2024: $17.13
- 2025: $25.42
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $25.42.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $25.42 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
87798
Detection test by nucleic acid for organism, amplified probe technique
|
7,138 | 392 | $40.75 | $30.34 |
|
G0483
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
|
4,495 | 776 | $325.00 | $241.98 |
|
80307
Testing for presence of drug, by chemistry analyzers
|
3,212 | 730 | $70.19 | $60.90 |
|
G0179
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a
|
1,707 | 616 | $60.00 | $40.02 |
|
87481
Detection test for candida species (yeast), amplified probe technique
|
1,294 | 262 | $51.05 | $34.39 |
|
G0181
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow
|
1,132 | 425 | $110.00 | $100.70 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
637 | 372 | $18.00 | $15.87 |
|
87640
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
|
538 | 372 | $50.00 | $34.39 |
|
99349
Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes
|
532 | 341 | $141.30 | $122.09 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
519 | 318 | $153.35 | $122.51 |
|
96132
Evaluation of neuropsychological test, first hour
|
507 | 474 | $259.69 | $124.64 |
|
96139
Administration of psychological or neuropsychological test by technician, each additional 30 minutes
|
467 | 465 | $115.00 | $33.06 |
|
95816
Measurement of brain wave activity (eeg), awake and drowsy
|
465 | 463 | $465.00 | $371.54 |
|
95957
Measurement of brain wave activity (eeg), digital analysis
|
465 | 463 | $214.38 | $212.58 |
|
96138
Administration of psychological or neuropsychological test by technician, first 30 minutes
|
464 | 462 | $60.00 | $32.13 |
|
93040
Electrocardiogram (ecg) 1 to 3 leads with review by physician
|
463 | 461 | $20.00 | $12.00 |
|
87651
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
|
447 | 332 | $50.00 | $34.39 |
|
99458
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes
|
438 | 47 | $88.36 | $37.75 |
|
99457
Management using the results of remote vital sign monitoring per calendar month, first 20 minutes
|
333 | 64 | $78.20 | $46.77 |
|
87563
Detection of mycoplasma genitalium by dna or rna probe
|
327 | 170 | $50.00 | $34.39 |
|
87486
Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique
|
293 | 268 | $50.14 | $34.39 |
|
87498
Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique
|
293 | 268 | $50.00 | $34.39 |
|
87581
Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique
|
293 | 268 | $45.15 | $34.39 |
|
87635
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen
|
293 | 268 | $89.88 | $50.26 |
|
87541
Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique
|
292 | 267 | $45.00 | $34.39 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 2,142 | 63,492 | $59,300.11 | 290 |
| Amlodipine Besylate | Amlodipine Besylate | 1,765 | 125,571 | $8,311.42 | 520 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 1,678 | 89,385 | $102,795.26 | 463 |
| Gabapentin | Gabapentin | 1,634 | 98,457 | $31,459.05 | 412 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1,512 | 104,510 | $11,166.39 | 420 |
| Furosemide | Furosemide | 1,010 | 64,870 | $4,930.12 | 288 |
| Diclofenac Sodium | Diclofenac Sodium | 1,008 | 37,106 | $401,111.51 | 249 |
| Lisinopril | Lisinopril | 881 | 57,881 | $4,481.36 | 229 |
| Alprazolam | Alprazolam | 834 | 24,675 | $6,867.93 | 103 |
| Trazodone Hcl | Trazodone Hcl | 752 | 51,519 | $7,083.49 | 213 |
| Metformin Hcl | Metformin Hcl | 723 | 47,847 | $4,599.67 | 194 |
| Fluticasone Propionate | Fluticasone Propionate | 674 | 37,472 | $10,798.36 | 195 |
| Tamsulosin Hcl | Tamsulosin Hcl | 635 | 42,167 | $6,625.90 | 173 |
| Ozempic | Semaglutide | 629 | 28,398 | $931,620.07 | 129 |
| Pantoprazole Sodium | Pantoprazole Sodium | 620 | 40,530 | $5,433.47 | 171 |
| Clonidine Hcl | Clonidine Hcl | 615 | 36,236 | $3,451.46 | 159 |
| Carvedilol | Carvedilol | 607 | 38,166 | $4,646.04 | 149 |
| Potassium Chloride | Potassium Chloride | 580 | 34,914 | $13,243.88 | 145 |
| Levothyroxine Sodium | Levothyroxine Sodium | 558 | 37,762 | $6,667.94 | 159 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 543 | 14,725 | $14,866.61 | 110 |
| Losartan Potassium | Losartan Potassium | 529 | 34,076 | $3,867.16 | 138 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 525 | 25,560 | $521,399.02 | 124 |
| Omeprazole | Omeprazole | 523 | 35,610 | $5,697.46 | 161 |
| Ventolin Hfa | Albuterol Sulfate | 473 | 22,157 | $46,282.72 | 172 |
| Montelukast Sodium | Montelukast Sodium | 466 | 33,484 | $4,360.44 | 127 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-11-20NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Medicine (M.D.)
Podiatrist - Foot & Ankle Surgery
Doctor of Podiatric Medicine
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 5072 W PLANO PKWY STE 220, PLANO, TX 750934475 (Tel: 4696710900)
Registered at 5072 W PLANO PKWY STE 220, PLANO, TX 750934475 (Tel: 4696710900)
NPI status registered as active in NPPES database
Registered at 6517 RIVEREDGE DRIVE, PLANO, TX 750246086 (Tel: 4696710900)
Registered at 6517 RIVEREDGE DRIVE, PLANO, TX 750246086 (Tel: 4696710900)
Recorded as ODETTE CAMPBELL, M.D.
Internal Medicine (license number reported to NPPES: TX H9609)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Plano
- Dr. Safoora Harandi, MD
- Dr. Saquib Ibrahim, MD
- Dr. Jennifer Zimmer, MD
- Dr. Mahvish Ayman, MD
- Dr. Deepa Moparty, MD
- Dr. Meesun Sim, MD
Mailing Address
5072 W Plano Pkwy Ste 220
Plano, TX 750934475
Phone: 4696710900